Insurers and the drug-industry middlemen they own stand to earn more as healthcare spending increases.
AdvertisementAdvertisementFor US health insurers, explosive demand for new weight-loss drugs likely means bigger profits.
Insurers and the drug-industry middlemen they own stand to earn more as weight-loss drugs drive up healthcare spending, BofA analysts wrote.
Meanwhile, if the drugs help people live longer, insurers could earn more from higher enrollment in their health plans.
As weight-loss drugs drive up healthcare spending, insurers will make more moneyWeight-loss drugs, which can cost around $1,000 a month, are driving up healthcare spending.
Persons:
Li Ran, Brian Evanko, Evernorth
Organizations:
Trilliant Health, Bank of America Global Research, Getty, Cigna, CVS Health, UnitedHealth Group, CVS, Kaiser Family Foundation
Locations:
Xinhua, GLP